Ali M. Nasr

1.0k total citations
30 papers, 794 citations indexed

About

Ali M. Nasr is a scholar working on Pharmaceutical Science, Food Science and Molecular Biology. According to data from OpenAlex, Ali M. Nasr has authored 30 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmaceutical Science, 7 papers in Food Science and 4 papers in Molecular Biology. Recurrent topics in Ali M. Nasr's work include Advancements in Transdermal Drug Delivery (8 papers), Drug Solubulity and Delivery Systems (8 papers) and Advanced Drug Delivery Systems (7 papers). Ali M. Nasr is often cited by papers focused on Advancements in Transdermal Drug Delivery (8 papers), Drug Solubulity and Delivery Systems (8 papers) and Advanced Drug Delivery Systems (7 papers). Ali M. Nasr collaborates with scholars based in Egypt, Saudi Arabia and Germany. Ali M. Nasr's co-authors include Mamdouh Ghorab, Ahmed R. Gardouh, Mona Qushawy, Shady A. Swidan, Reda F.M. Elshaarawy, Amgad I. M. Khedr, J. Alkabli, Yasser A. Hassan, Shadeed Gad and Mehrez E. El‐Naggar and has published in prestigious journals such as Carbohydrate Polymers, Molecules and Frontiers in Microbiology.

In The Last Decade

Ali M. Nasr

27 papers receiving 778 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ali M. Nasr 412 142 129 117 87 30 794
Marwa Hasanein Asfour 329 0.8× 140 1.0× 109 0.8× 171 1.5× 81 0.9× 22 777
Baode Shen 420 1.0× 188 1.3× 172 1.3× 109 0.9× 86 1.0× 66 986
Farhat Fatima 321 0.8× 140 1.0× 180 1.4× 92 0.8× 87 1.0× 43 773
Shefaat Ullah Shah 397 1.0× 113 0.8× 165 1.3× 81 0.7× 54 0.6× 52 746
Chengying Shen 411 1.0× 277 2.0× 150 1.2× 90 0.8× 78 0.9× 60 1.0k
Jyotsana Madan 487 1.2× 165 1.2× 78 0.6× 127 1.1× 96 1.1× 44 875
Loaye Al Shaal 418 1.0× 187 1.3× 139 1.1× 144 1.2× 107 1.2× 8 854
Jin Han 381 0.9× 207 1.5× 176 1.4× 94 0.8× 86 1.0× 52 920
Sonia Pandey 491 1.2× 199 1.4× 121 0.9× 92 0.8× 49 0.6× 41 873
Harinath N. More 341 0.8× 227 1.6× 136 1.1× 128 1.1× 79 0.9× 97 998

Countries citing papers authored by Ali M. Nasr

Since Specialization
Citations

This map shows the geographic impact of Ali M. Nasr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali M. Nasr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali M. Nasr more than expected).

Fields of papers citing papers by Ali M. Nasr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali M. Nasr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali M. Nasr. The network helps show where Ali M. Nasr may publish in the future.

Co-authorship network of co-authors of Ali M. Nasr

This figure shows the co-authorship network connecting the top 25 collaborators of Ali M. Nasr. A scholar is included among the top collaborators of Ali M. Nasr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali M. Nasr. Ali M. Nasr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alfaifi, Mohammad Y., Nuha Y. Elamin, Ali M. Nasr, et al.. (2025). Neuroprotective role of thyme polyphenols-loaded β-cyclodextrin–chitosan nanocarriers against cisplatin-induced brain toxicity: In vivo studies and molecular mechanisms. Journal of Drug Delivery Science and Technology. 115. 107791–107791.
2.
3.
Alrashdi, Barakat M., Diaa Massoud, Shahenda Mahgoub, et al.. (2024). The Protecting Role of Black Seed Oil and Its Nano-Formulation in LPS-Induced Acute Kidney Injury in Mice: Evaluation of Oxidative Stress, Biochemical & Molecular Parameters. Journal of Inflammation Research. Volume 17. 4747–4763. 2 indexed citations
5.
Gad, Shadeed, et al.. (2024). A recent review on polymeric nanoparticles: Structure, Classification, and preparation methods. 8(3). 58–66. 1 indexed citations
6.
Nasr, Ali M., et al.. (2023). Development, Optimization, and In Vitro/In Vivo Evaluation of Azelaic Acid Transethosomal Gel for Antidermatophyte Activity. Antibiotics. 12(4). 707–707. 12 indexed citations
8.
Shati, Ali A., Mohammad Y. Alfaifi, Fawziah A. Al‐Salmi, et al.. (2023). Therapeutic potential and protection enhancement of mesenchymal stem cell against cisplatin-induced nephrotoxicity using hyaluronic acid-chitosan nanoparticles as an adjuvant. International Journal of Pharmaceutics. 640. 123023–123023. 10 indexed citations
9.
Khedr, Amgad I. M., Ali M. Nasr, Shady A. Swidan, et al.. (2022). Silver Nanoparticles Formulation of Flower Head’s Polyphenols of Cynara scolymus L.: A Promising Candidate against Prostate (PC-3) Cancer Cell Line through Apoptosis Activation. Molecules. 27(19). 6304–6304. 9 indexed citations
10.
Khedr, Amgad I. M., Ali M. Nasr, Shady A. Swidan, et al.. (2022). Comparative Estimation of the Cytotoxic Activity of Different Parts of Cynara scolymus L.: Crude Extracts versus Green Synthesized Silver Nanoparticles with Apoptotic Investigation. Pharmaceutics. 14(10). 2185–2185. 13 indexed citations
11.
Nasr, Ali M., Mohammad Y. Alfaifi, Ali A. Shati, et al.. (2022). Upgrading the Transdermal Biomedical Capabilities of Thyme Essential Oil Nanoemulsions Using Amphiphilic Oligochitosan Vehicles. Pharmaceutics. 14(7). 1350–1350. 31 indexed citations
12.
Abdelhameed, Reda F. A., Mohamed S. Nafie, Ali M. Nasr, et al.. (2022). Comparative Cytotoxic Evaluation of Zygophyllum album Root and Aerial Parts of Different Extracts and Their Biosynthesized Silver Nanoparticles on Lung A549 and Prostate PC-3 Cancer Cell Lines. Pharmaceuticals. 15(11). 1334–1334. 7 indexed citations
13.
Nasr, Ali M., Salama Mostafa Aboelenin, Mohammad Y. Alfaifi, et al.. (2022). Quaternized Chitosan Thiol Hydrogel-Thickened Nanoemulsion: A Multifunctional Platform for Upgrading the Topical Applications of Virgin Olive Oil. Pharmaceutics. 14(7). 1319–1319. 19 indexed citations
14.
Darwish, Khaled M., Mohamed A. Tantawy, Ali M. Nasr, et al.. (2021). Design, Synthesis, Anticancer Activity, and Solid Lipid Nanoparticle Formulation of Indole- and Benzimidazole-Based Compounds as Pro-Apoptotic Agents Targeting Bcl-2 Protein. Pharmaceuticals. 14(2). 113–113. 24 indexed citations
15.
Hassan, Yasser A., Amgad I. M. Khedr, J. Alkabli, Reda F.M. Elshaarawy, & Ali M. Nasr. (2021). Co-delivery of imidazolium Zn(II)salen and Origanum Syriacum essential oil by shrimp chitosan nanoparticles for antimicrobial applications. Carbohydrate Polymers. 260. 117834–117834. 55 indexed citations
16.
Nasr, Ali M., Sameh S. Elhady, Shady A. Swidan, & Noha M. Badawi. (2020). Celecoxib Loaded In-Situ Provesicular Powder and Its In-Vitro Cytotoxic Effect for Cancer Therapy: Fabrication, Characterization, Optimization and Pharmacokinetic Evaluation. Pharmaceutics. 12(12). 1157–1157. 6 indexed citations
18.
Nasr, Ali M., et al.. (2016). EFFECT OF OILS, SURFACTANTS AND COSURFACTANTS ON PHASE BEHAVIOR AND PHYSICOCHEMICAL PROPERTIES OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) FOR IRBESARTAN AND OLMESARTAN. International Journal of Applied Pharmaceutics. 8(1). 13–24. 21 indexed citations
20.
Ghorab, Mamdouh, et al.. (2014). EFFECT OF ADDITIVES ON IN-VITRO RELEASE OF ORODISPERSIBLE DOSAGE FORM. International Journal of Pharmacy and Pharmaceutical Sciences. 7(2). 283–289. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026